Optimal time between completion of preoperative chemotherapy and surgery for locally advanced pancreatic cancer
Multimodal treatment with preoperative chemotherapy is increasingly used for locally advanced pancreatic cancer (LAPC) to enable surgical resection. However, the optimal time between the last cycle of preoperative chemotherapy and surgery remains unclear. This study aimed to evaluate the association...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
03 March 2026
|
| In: |
Annals of surgical oncology
Year: 2026, Volume: 33, Issue: 6, Pages: 5060-5067 |
| ISSN: | 1534-4681 |
| DOI: | 10.1245/s10434-026-19264-2 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1245/s10434-026-19264-2 |
| Author Notes: | Marionna Cathomas, Christoph Kahlert, Thomas Hank, Ingmar Rompen, Maximilian Kryschi, Ulf Hinz, Thilo Hackert, Mohammed Al-Saeedi, Markus W. Büchler, Martin Loos |
| Summary: | Multimodal treatment with preoperative chemotherapy is increasingly used for locally advanced pancreatic cancer (LAPC) to enable surgical resection. However, the optimal time between the last cycle of preoperative chemotherapy and surgery remains unclear. This study aimed to evaluate the association between timing of surgery after preoperative chemotherapy and overall survival of patients with LAPC. |
|---|---|
| Item Description: | Gesehen am 22.05.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1534-4681 |
| DOI: | 10.1245/s10434-026-19264-2 |